Biotechnology Stocks I Performance Guide: Xenon Pharmaceuticals Inc. (XENE)
XENE has no dividends
Table and Chart of XENE Performance
See what a $1,000 investment in XENE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| XENE Returns | |
|---|---|
| Start Date | Dec-31-2014 |
| Start Price | $19.75 |
| End Date | Dec-01-2023 |
| End Price | $36.80 |
| # Prices | 109 |
| Min Date | Nov-30-2017 |
| Min Price | $2.45 |
| Max Date | Apr-28-2023 |
| Max Price | $40.28 |
| Total Return | 86.33% |
| Annualized Return | 7.09% |
| Current Value of $1,000 Purchase | $1,863 |
| Number Returns | 5,886 |
| Average Return | 165.82% |
| Number Profitable Returns | 4,598 |
| Percent Profitable Returns | 78.12% |
| Number Unprofitable Returns | 1,288 |
| Percent Unprofitable Returns | 21.88% |
| Profitable to Unprofitable Returns Ratio | 3.57 |
| XENE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,407,813,000 | Price to Sales | 181.44 |
| Earnings per Share | $-2.6600 |
| PE Ratio | None |
| PE to Growth Ratio | -0.06 |
| Price to Book | 3.787 |
| PRICE DATA | |
| 52 Week High | $43.75 |
| 52 Week Low | $27.98 |
| Analyst Target Price | $52.5 |
| 50-Day Moving Average | $32.96 |
| 200-Day Moving Average | $36.88 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.252% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
XENE Compare Returns with S&P 500
XENE Trendline Chart